As Reported by the House Health Committee
132nd General Assembly
Regular Session Sub. H. B. No. 167
2017-2018
Representative Edwards
Cosponsor: Representative Householder
A BILL
To amend sections 4723.52, 4730.56, 4731.83, and 5119.363, to amend, for the purpose of adopting a new section number as indicated in parentheses, section 3715.08 (3719.064), and to enact sections 3719.063 and 4729.283 of the Revised Code regarding naltrexone and medication-assisted treatment.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:
Section 1. That sections 4723.52, 4730.56, 4731.83, and 5119.363 be amended, section 3715.08 (3719.064) be amended for the purpose of adopting a new section number as indicated in parentheses, and sections 3719.063 and 4729.283 of the Revised Code be enacted to read as follows:
Sec. 3719.063. In the absence of gross negligence or intentional misconduct, a person who administers the drug naltrexone by injection, the person's employer, and the facility at which the drug is administered are not liable in any civil action or subject to criminal prosecution or professional discipline for any injury or damage caused by the injection or drug if all of the following conditions are met:
(A) The individual to whom the drug is administered is unable to have it administered as follows:
(1) By a person who routinely administers the drug to the individual;
(2) At the facility at which the drug is routinely administered to the individual;
(3) Under the direction of the drug's prescriber.
(B) The person who administers the drug under this section is legally authorized to administer it by injection but is not the prescriber of the drug or one who routinely administers it to the individual.
(C) The drug is provided to the person who administers it under this section in either of the following ways:
(1) By the individual to whom it is administered;
(2) By the pharmacy that has a record of a prescription for the drug in the name of the individual to whom it is administered.
(D) The person who administers the drug under this section is authorized to do so by that person's employer or the facility at which the drug is administered.
Sec.
3715.08
3719.064.
(A) As used in this section:
(1) "Medication-assisted treatment" has the same meaning as in section 340.01 of the Revised Code.
(2) "Prescriber" means any of the following:
(a) An advanced practice registered nurse who holds a current, valid license issued under Chapter 4723. of the Revised Code and is designated as a clinical nurse specialist, certified nurse-midwife, or certified nurse practitioner;
(b) A physician authorized under Chapter 4731. of the Revised Code to practice medicine and surgery or osteopathic medicine and surgery;
(c) A physician assistant who is licensed under Chapter 4730. of the Revised Code, holds a valid prescriber number issued by the state medical board, and has been granted physician-delegated prescriptive authority.
(3) "Qualifying practitioner" has the same meaning as in section 303(g)(2)(G)(iii) of the "Controlled Substances Act of 1970," 21 U.S.C. 823(g)(2)(G)(iii), as amended.
(B) Before initiating medication-assisted treatment, a prescriber shall give the patient or the patient's representative information about all drugs approved by the United States food and drug administration for use in medication-assisted treatment. The information must be provided both orally and in writing. The prescriber or the prescriber's delegate shall note in the patient's medical record when this information was provided and make the record available to employees of the board of nursing or state medical board on their request.
If the prescriber is not a qualifying practitioner and the patient's choice is treatment with a controlled substance containing buprenorphine and the prescriber determines that such treatment is clinically appropriate and meets generally accepted standards of medicine, the prescriber shall refer the patient to a qualifying practitioner. If the patient's choice is methadone treatment and the prescriber determines that such treatment is clinically appropriate and meets generally accepted standards of medicine, the prescriber shall refer the patient to a community addiction services provider licensed under section 5119.391 of the Revised Code. In either case, the prescriber or the prescriber's delegate shall make a notation in the patient's medical record naming the practitioner or provider to whom the patient was referred and specifying when the referral was made.
Sec. 4723.52. (A) As used in this section:
(1) "Community addiction services provider" has the same meaning as in section 5119.01 of the Revised Code.
(2) "Medication-assisted treatment" has the same meaning as in section 340.01 of the Revised Code.
(B)
An advanced practice registered nurse shall comply with
section 3715.08
3719.064
of
the Revised Code and rules adopted
under section 4723.51 of the Revised Code when treating a
patient for addiction with medication-assisted treatment or proposing
to initiate such treatment.
(C) An advanced practice registered nurse who fails to comply with this section shall treat not more than thirty patients at any one time with medication-assisted treatment even if the facility or location at which the treatment is provided is either of the following:
(1) Exempted by divisions (B)(2)(a) to (d) of section 4729.553 of the Revised Code from being required to possess a category III terminal distributor of dangerous drugs license with an office-based opioid treatment classification;
(2) A community addiction services provider that provides alcohol and drug addiction services that are certified by the department of mental health and addiction services under section 5119.36 of the Revised Code.
Sec. 4729.283. (A) A pharmacist may dispense naltrexone without a written or oral prescription from a licensed health professional authorized to prescribe drugs if all of the following conditions are met:
(1) The pharmacist is able to verify a record of a prescription for the injectable long-acting or extended-release form of naltrexone in the name of the patient who is requesting the drug, but the prescription does not provide for a refill or the time permitted by rules adopted by the state board of pharmacy for providing refills has elapsed.
(2) The pharmacist is unable to obtain authorization to refill the prescription from the prescriber who issued it or another prescriber responsible for the patient's care.
(3) In the exercise of the pharmacist's professional judgment:
(a) The drug is necessary to continue the patient's therapy for substance use disorder.
(b) Failure to dispense the drug to the patient could result in harm to the health of the patient.
(B) Before dispensing naltrexone under this section, the pharmacist shall offer the patient the choice of receiving either the oral form or injectable long-acting or extended-release form, but only if both forms of the drug are available for dispensing at the time of the patient's request or within one day after the request.
(C)(1) With respect to naltrexone dispensed in an oral form under this section, the pharmacist shall not dispense an amount that exceeds a five-day supply.
(2) With respect to naltrexone dispensed in an injectable long-acting or extended-release form under this section, both of the following apply:
(a) The pharmacist shall exercise professional judgment in determining the amount of the drug dispensed.
(b) The pharmacist may administer the drug by injection to the patient but only in accordance with section 4729.45 of the Revised Code.
(D) A pharmacist who dispenses naltrexone under this section shall do all of the following:
(1) For one year after the date of dispensing, maintain a record in accordance with this chapter of the drug dispensed, including the amount and form dispensed, the original prescription number, the name and address of the patient and, if the individual receiving the drug is not the patient, the name and address of that individual;
(2) Notify the prescriber who issued the prescription described in division (A)(1) of this section or another prescriber responsible for the patient's care not later than five days after the drug is dispensed;
(3) If applicable, obtain authorization for additional dispensing from one of the prescribers described in division (D)(2) of this section.
(E) A pharmacist shall exercise professional judgment in determining the number of times naltrexone may be dispensed under this section to the same patient.
(F) This section does not limit the authority of a pharmacist to dispense a dangerous drug under section 4729.281 of the Revised Code.
Sec. 4730.56. (A) As used in this section:
(1) "Community addiction services provider" has the same meaning as in section 5119.01 of the Revised Code.
(2) "Medication-assisted treatment" has the same meaning as in section 340.01 of the Revised Code.
(B)
A physician assistant shall comply with section 3715.08
3719.064
of
the Revised Code and rules adopted under section
4730.55 of the Revised Code when treating a patient with
medication-assisted
treatment or proposing to initiate such treatment.
(C) A physician assistant who fails to comply with this section shall treat not more than thirty patients at any one time with medication-assisted treatment even if the facility or location at which the treatment is provided is either of the following:
(1) Exempted by divisions (B)(2)(a) to (d) of section 4729.553 of the Revised Code from being required to possess a category III terminal distributor of dangerous drugs license with an office-based opioid treatment classification;
(2) A community addiction services provider that provides alcohol and drug addiction services that are certified by the department of mental health and addiction services under section 5119.36 of the Revised Code.
Sec. 4731.83. (A) As used in this section:
(1) "Medication-assisted treatment" has the same meaning as in section 340.01 of the Revised Code.
(2) "Physician" means an individual authorized by this chapter to practice medicine and surgery or osteopathic medicine and surgery.
(B)
A physician shall comply with section 3715.08
3719.064
of
the Revised Code and rules adopted under section 4731.056 of the
Revised Code when treating a patient with medication-assisted
treatment or proposing to initiate such treatment.
(C) A physician who fails to comply with this section shall treat not more than thirty patients at any one time with medication-assisted treatment even if the facility or location at which the treatment is provided is either of the following:
(1) Exempted by divisions (B)(2)(a) to (d) of section 4729.553 of the Revised Code from being required to possess a category III terminal distributor of dangerous drugs license with an office-based opioid treatment classification;
(2) A community addiction services provider that provides alcohol and drug addiction services that are certified by the department of mental health and addiction services under section 5119.36 of the Revised Code.
Sec. 5119.363. The director of mental health and addiction services shall adopt rules governing the duties of boards of alcohol, drug addiction, and mental health services under section 340.20 of the Revised Code and the duties of community addiction services providers under section 5119.362 of the Revised Code. The rules shall be adopted in accordance with Chapter 119. of the Revised Code.
The
director shall adopt rules under this section that authorize
the department of mental health and addiction services to
determine an advanced practice registered nurse's, physician
assistant's,
or physician's compliance with section 3715.08
3719.064
of
the Revised Code if such practitioner works for a community
addiction services provider.
Section 2. That existing section 3715.08, 4723.52, 4730.56, 4731.83, and 5119.363 of the Revised Code are hereby repealed.